Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era

How to identify follicular lymphoma (FL) patients with low disease burden but high risk for early progression is unclear. Building on a prior study demonstrating the early transformation of FLs with high variant allele frequency (VAF) BCL2 mutations at activation-induced cytidine deaminase (AICDA) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Correia, Cristina, Maurer, Matthew J., McDonough, Samantha J., Schneider, Paula A., Ross, Paige E., Novak, Anne J., Feldman, Andrew L., Cerhan, James R., Slager, Susan L., Witzig, Thomas E., Eckloff, Bruce W., Li, Hu, Nowakowski, Grzegorz S., Kaufmann, Scott H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188323/
https://www.ncbi.nlm.nih.gov/pubmed/37193683
http://dx.doi.org/10.1038/s41408-023-00847-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188323/
https://www.ncbi.nlm.nih.gov/pubmed/37193683
http://dx.doi.org/10.1038/s41408-023-00847-1

Ejemplares similares